July 19, 2024 11:10 AM EDT
News Briefing

Rona Ther­a­peu­tics rais­es $35M; Ac­tu­ate now plans for $22M IPO

ENDPOINTS

Shang­hai-based RNA com­pa­ny rais­es $35 mil­lion: Rona Ther­a­peu­tics’ Se­ries A+ round was led by Lon­gRiv­er In­vest­ments. In­vestors in­clude Lil­ly Asia Ven­tures …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

CBER's deputy di­rec­tor de­parts as staff shake­up con­tin­ues

Blue­bird bio to sell to in­vest­ment funds af­ter strug­gling to make mon­ey from gene ther­a­pies

Pfiz­er CEO says op­por­tu­ni­ties with Trump ‘clear­ly out­weigh’ the risks for phar­ma

FDA ap­proves first drug to treat ul­tra-rare lipid stor­age dis­ease

Eli Lil­ly stock­piles $548M of oral weight loss drug ahead of launch

sponsored

Trust­ed pro­tec­tion: Why the cur­rent meningo­coc­cal vac­ci­na­tion sched­ule shouldn’t change with­out strong ev­i­dence

A service from the Financial Times